These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18855874)

  • 21. Clinical predictors and time course of arrhythmia recurrence in patients with early reinitiation of atrial fibrillation after successful internal cardioversion.
    Tse HF; Lau CP
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1809-14. PubMed ID: 12930494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
    Tieleman RG; Van Gelder IC; Bosker HA; Kingma T; Wilde AA; Kirchhof CJ; Bennekers JH; Bracke FA; Veeger NJ; Haaksma J; Allessie MA; Crijns HJ
    Heart Rhythm; 2005 Mar; 2(3):223-30. PubMed ID: 15851308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stunning of the left atrium after conversion of atrial fibrillation: predictor for maintenance of sinus rhythm?
    Okçün B; Yigit Z; Arat A; Baran T; Küçükoglu MS
    Echocardiography; 2005 May; 22(5):402-7. PubMed ID: 15901291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of total atrial conduction time measured with tissue Doppler imaging to predict the maintenance of sinus rhythm after external electrical cardioversion of persistent atrial fibrillation.
    Maffè S; Paffoni P; Dellavesa P; Cucchi L; Zenone F; Bergamasco L; Paino AM; Franchetti Pardo N; Signorotti F; Baduena L; Parravicini U
    Echocardiography; 2015 Mar; 32(3):420-7. PubMed ID: 25047126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation.
    Nergårdh A; Frick M
    Heart; 2006 Sep; 92(9):1244-7. PubMed ID: 16547207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion.
    Oral H; Ozaydin M; Sticherling C; Tada H; Scharf C; Chugh A; Lai SW; Pelosi F; Knight BP; Strickberger SA; Morady F
    J Cardiovasc Electrophysiol; 2003 Feb; 14(2):182-5. PubMed ID: 12693502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autonomic modulation of the sinus node following electrical cardioversion of persistent atrial fibrillation: relation with early recurrence.
    Bertaglia E; Zoppo F; Bonanno C; Pellizzari N; Frigato N; Pascotto P
    Int J Cardiol; 2005 Jul; 102(2):219-23. PubMed ID: 15982488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of atrial electromechanical delay for atrial fibrillation recurrence.
    Ari H; Ari S; Akkaya M; Aydin C; Emlek N; Sarigül OY; Çetinkaya S; Bozat T; Şentürk M; Karaağaç K; Melek M; Yilmaz M
    Cardiol J; 2013; 20(6):639-47. PubMed ID: 24338542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation.
    Nergärdh A; Nordlander R; Frick M
    Clin Cardiol; 2006 Feb; 29(2):56-60. PubMed ID: 16506639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial pressure pattern without a-wave in sinus rhythm after cardioversion affects the outcomes after catheter ablation for atrial fibrillation.
    Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
    Heart Vessels; 2018 Nov; 33(11):1365-1372. PubMed ID: 29691642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
    Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
    Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans.
    Hobbs WJ; Fynn S; Todd DM; Wolfson P; Galloway M; Garratt CJ
    Circulation; 2000 Mar; 101(10):1145-51. PubMed ID: 10715261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of early direct current cardioversion on the recurrence of atrial fibrillation in patients with persistent atrial fibrillation.
    Osmanagic A; Möller S; Osmanagic A; Sheta HM; Vinther KH; Egstrup K
    Am J Cardiol; 2015 Jul; 116(2):225-9. PubMed ID: 25972054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel echocardiographic predictor of atrial fibrillation recurrence: L-wave.
    Ari H; Ari S; Akkaya M; Yasar Sarigul O; Emlek N; Aydin C; Çetinkaya S; Bozat T; Melek M
    Echocardiography; 2013 Nov; 30(10):1180-6. PubMed ID: 23742118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between left atrial phasic conduit function and early atrial fibrillation recurrence in patients undergoing electrical cardioversion.
    Degiovanni A; Boggio E; Prenna E; Sartori C; De Vecchi F; Marino PN;
    Clin Res Cardiol; 2018 Apr; 107(4):329-337. PubMed ID: 29181725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation.
    Korantzopoulos P; Kolettis TM; Kountouris E; Dimitroula V; Karanikis P; Pappa E; Siogas K; Goudevenos JA
    Int J Cardiol; 2005 Jul; 102(2):321-6. PubMed ID: 15982504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of Failed Electrical Cardioversion for Early Recurrence After Catheter Ablation for Atrial Fibrillation as a Predictor of Future Recurrence.
    Nakamaru R; Tanaka N; Okada M; Tanaka K; Ninomiya Y; Hirao Y; Oka T; Inoue H; Koyama Y; Okamura A; Iwakura K; Rakugi H; Sakata Y; Fujii K; Inoue K
    Am J Cardiol; 2019 Mar; 123(5):794-800. PubMed ID: 30558757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.
    Siu CW; Jim MH; Zhang X; Chan YH; Pong V; Kwok J; Kung AW; Lau CP; Tse HF
    Am J Cardiol; 2009 Feb; 103(4):540-3. PubMed ID: 19195517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation.
    Makowski M; Smorag I; Makowska J; Bissinger A; Grycewicz T; Paśnik J; Kidawa M; Lubiński A; Zielińska M; Baj Z
    Int J Cardiol; 2017 May; 235():1-5. PubMed ID: 28302320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.